Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 2, 1997, Pages 259-267

  Stuschke, Martin ^a,c   Thames, Howard D ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Altered fractionation; Fractionation sensitivity; Hyperfractionation; Metaanalysis; Phase III clinical trials

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; GLIOBLASTOMA; HEAD AND NECK TUMOR; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS, PHASE III; GLIOMA; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; ODDS RATIO; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT FAILURE; URINARY BLADDER NEOPLASMS;

EID: 0030888060     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00511-1     Document Type: Article

References (46)

1. Awwad, H. K.; Khafagy, Y.; Barsoum, M.; Ezzat, S.; El-Attar, I.; Farag, H.; Akoush, H.; Meabid, H.; Zaghloul, M. S. Accelerated vs. conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: Influence of tumor proliferation. Radiother. Oncol. 25:261-266; 1992.
2. Baumann, M. Fraktionierungseffekt der Strahlenwirkung auf FaDu-Tumoren. Hamburg: Proceedings of the Third Symposium on Experimental Radiotherapy and Radiation Biology, University of Hamburg; 1994:19-24.
3. Beck-Bornholdt, H.-P.; Maurer, T.; Becker, S.; Omniczynski, M.; Vogler, H.; Würschmidt, F. Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation - 126 fractions applied within 6 weeks. Int. J. Radiat. Oncol. Biol. Phys. 16:701-705; 1989.
4. Bentzen, S. M.; Overgaard, J.; Thames, H. D.; Overgaard, M.; Vejby Hansen, P.; von der Maase, H.; Melder, J. Clinical radiobiology of malignant melanoma. Radiother. Oncol. 16:169-182; 1989.
5. Chalmers, T. C.; Smith, H.; Blackburn, B.; Silverman, B.; Schroeder, B.; Reitman, D. Controlled Clin. Trials 2:31-49; 1981.
6. Datta, N. R.; Choudhry, A. D.; Gupta, S. Twice a day vs. once a day radiation therapy in head and neck cancer (Abstr.). Int. J. Radiat. Oncol. Biol. Phys. 17(Suppl. 1):132; 1989.
7. Deutsch, M.; Green, S. B.; Strike, T. A.; Burger, P. C.; Robertson, J. T.; Selker, R. G.; Shapiro, W. R.; Mealey, J.; Ronsohoff, J.; Paoletti, P.; Smith, K. R.; Odom, G. L.; Hun,t, W. E.; Young, B.; Alexander, E.; Walker, M. D.; Pistenmaa, D. A. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 16:1389-1396; 1989.
8. Dische, S.; Saunders, I.; Barrett, A. The first report of the CHART randomised trials. In: Hagen, U.; Jung, H.; Streffer, C., eds. Radiation research 1895-1995. Proceedings of the tenth international congress of radiation research. Würzburg, Germany, August 27-September 1, Vol. 1, Würzburg, Universitätsdruckerei Stürtz AG; 1995;21.
9. Early Breast Cancer Trialists Collaborative Group. In: Treatment of early breast cancer Oxford: Oxford University Press 1; 1990.
10. Edsmyr, F.; Andersson, L.; Esposti, P. L.; Littbrand, B.; Nilsson, B. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother. Oncol. 4:197-203; 1985.
11. Fallai, C.; Olmi, P. Altered fractionation schedules in radiotherapy of head and neck cancer. A review. Tumori 78:311-325; 1992.
12. Fine, H. A.; Dera, K. B. G.; Loeffler, J. S.; Black, P.; Canellos, G. P. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585-2597; 1993.
13. Fu, S.; Jiang, G. L.; Wang, J. L. Hyperfractionated irradiation for nonsmall cell lung cancer - A phase III clinical trial. Chung Hua Chung Liu Tsa Chih. 16:306-309; 1994.
14. Fulton, D. S.; Urtasun, R. C.; Shin, K. H.; Geggie, P. H. S.; Thomas, H.; Muller, P. J.; Moody, J.; Tanasichuk, R. N.; Mielke, B.; Johnson, E.; Curry, B. Misonidazole combined with hyperfractionation in the management of malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 10:1709-1712; 1984.
15. Goldobenko, G. V.; Matveev, B. P.; Shipilov, V. I.; Kilmakov, B. D.; Takachev, S. I. Radiation treatment of bladder cancer using different fractionation regimes. Med. Radiol. Mosk. 36:14-16; 1991.
16. Gonzalez Gonzalez, D.; Haveman, J. Effects of irradiation by single or multiple fractions per day on a transplantable murine mammary carcinoma. Br. J. Radiol. 55:916-921; 1982.
17. Guttenberger, R.; Kummermehr, J.; Chmelevsky, D. Kinetics of recovery from sublethal radiation damage in four murine tumors. Radiother. Oncol. 18:79-88; 1990.
18. Horiot, J. C.; Bontemps, P.; Begg, A. C.; LeFur, R.; van den Bogaert, W.; Bolla, M.; N Guyen, T.; van den Weijngaert, D.; Bernier, J.; Lusinchi, A.; Stuschke, M.; Lopez Torrecilla, D.; Jancar, B.; van Glabbeke, M.; Pierat, M. Hyperfractionated and accelerated radiotherapy in head and neck cancers: Facts from trials, impact on standard practice (Abstr.). Eur. J. Cancer 31A(Suppl. 5):S 69; 1995.
19. Horiot, J. C.; Le Fur, R.; N Guyen, T.; Chenal, C.; Schraub, S.; Alfonsi, S.; Gardant, G.; Van Den Bogaert, W.; Danczak, S.; Bolla, M.; Van Glabbeke, M.; De Pauw, M. Hyperfractionation vs. conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol. 25:231-241; 1992.
20. International Union Against Cancer (UICC). , 3rd ed. TNM classification of malignant tumors. Genève: UICC; 1979.
21. Johnson, D. H.; Kim, K.; Turrisi, A. T.; Sause, W.; Komaki, R.; Wagner, H.; Blum, R. Cisplatin & etoposide + concurrent thoracic radiotherapy adminstered once vs. twice daily for limited-stage small cell lung cancer: Preliminary results of an Intergroup trial. Proc. Annu. Meet. Am. Soc. Clin. Oncol. 13:A1105; 1994.
22. Kagami, Y.; Nishio, M.; Narimatsu, N.; Ogawa, H.; Sakurai, T. Prospective randomized trials comparing hyperfractionated radiotherapy with vonventional radiotherapy in Stage III nonsmall cell lung cancer. Nippon-Igaku-Hoshasen-Gakkai-Zasshi 52:1452-1455; 1992.
23. Kalbfleisch, J. D.; Prentice, R. L. The statistical analysis of failure time data. New York: J. Wiley & Sons; 1980.
24. Lindenberger, J.; Hermeking, H.; Kummermehr, J.; Denekamp, J. Response of human tumour xenografts to fractionated X-irradiation. Radiother. Oncol. 6:15-17; 1986.
25. Marcial, V. A.; Pajak, T. F.; Chang, C.; Tupchong, L.; Stetz, J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: preliminary report by the Radiation Therapy Oncology Group (RTOG). Int. J. Radiat. Oncol. Biol. Phys. 13:41-47; 1987.
26. Marino, P.; Preatoni, A.; Cantoni, A. Randomized trials of radiotherapy alone vs. combined chemotherapy and radiotherapy in Stages IIIa and IIIb nonsmall cell lung cancer. Cancer 76:593-601; 1995.
27. McGinn, C. J.; Harari, P. M.; Fowler, J. F.; Ford, C. N.; Pyle, G. M.; Kinsella, T. J. Dose intensification in curative head and neck cancer radiotherapy - Linear quadratic analysis and preliminary assessment of clinical results. Int. J. Radiat. Oncol. Biol. Phys. 27:363-369; 1993.
28. Payne, D. G.; Simpson, W. J.; Keen, C.; Platts, M. E. Malignant astrocytoma. Cancer 50:2301-2306; 1982.
29. Peng, K. G. Comparison of three different fractionations in radiotherapy for esophageal carcinoma - A prospective randomized trial on 80 patients. Chung Hua Chung Liu Tsa Chih. 13:232-234; 1991.
30. Pinto, L. H. J.; Canary, P. C. V.; Araújo, C. M. M.; Bacelar, S. C.; Souhami, L. Prospective randomized trial comparing hyperfractionated vs. conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 21:557-562; 1991.
31. Rofstad, E. K. Fractionation sensitivity (α/β ratio) of human melanoma xenografts. Radiother. Oncol. 33:133-138; 1994.
32. Sanchíz, F.; Milla, A.; Torner, J.; Bonet, F.; Artola, N.; Carreno, L.; Moya, L. M.; Riera, D.; Ripol, S.; Cirera, L. Single fraction per day vs. two fractions per day vs. radiochemotherapy in the treatment of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 19:1347-350; 1990.
33. Sause, W. T.; Cooper, J. S.; Rush, S.; Ago, C. T.; Cosmatos, D.; Coughlin, C. T.; JanJan, N.; Lipsett, J. Fraction size in external beam radiation therapy in the treatment of melanoma. Int. J. Radiat. Oncol. Biol. Phys. 20:429-432; 1991.
34. Sause, W. T.; Scott, C.; Taylor, S.; Johnson, D.; Livingston, R.; Komaki, R.; Cox, J. D; Emami, B.; Curran, W. J.; Byhardt, R. W.; Dar, A. R.; Turrisi, A. T. RTOG 88-08 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable nonsmall-cell lung cancer with minimum three year follow-up (Abstr.). Int. J. Radiat. Oncol. Biol. 32(Suppl. 1):195; 1995.
35. Sause, W. T.; Scott, C.; Taylor, S.; Johnson, D.; Livingston, R.; Komaki, R.; Emami, B.; Curran, W. J.; Byhardt, R. W.; Turrisi, A. T.; Dar, A. R.; Cox, J. D. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable nonsmall-cell lung cancer. J. Natl. Cancer Inst. 87:198-205; 1995.
36. Shin, K. H.; Muller, P. J.; Geggie, P. H. S. Superfractionation radiotherapy in the treatment of malignant astrocytoma. Cancer 52:2040-2043; 1983.
37. Stuschke, M.; Budach, V.; Stüben, G.; Streffer, C.; Sack, H. Heterogeneity in the fractionation sensitivities of human tumor cell lines: Studies in a three-dimensional model system. Int. J. Radiat. Oncol. Biol. Phys. 32:395-408; 1995.
38. Thames, H. D.; Bentzen, S. M.; Turesson, I.; Overgaard, M.; Van den Bogaert, W. Time-dose factors in radiotherapy: A review of the human data. Radiother. Oncol. 19:219-235; 1990.
39. Thames, H. D.; Withers, H. R.; Peters, L. J.; Fletcher, G. H. Changes in early and late radiation responses with altered dose fractionation: Implications for μ dose-survival relationships. Int. J. Radiat. Oncol. Biol. Phys. 8:219-226; 1982.
40. Turesson, I. Characteristics of dose-response relationships for late radiation effects: An analysis of skin telangiectasia and of head and neck morbidity. Radiother. Oncol. 20:149-158; 1991.
41. van den Bogaert, W.; van der Schueren, E.; Horiot, J.-C.; Chaplain, G.; Devilhena, M.; Raposo, S.; Leonor, J.; Schraub, S.; Chenal, C.; Barthelme, E.; Daban, A.; Eschwege, F.; Gonzalez, D.; Leer, J.-W.; Hamers, H.; Svoboda, V.; Rigon, A.; Arcangeli, G.; Sack, H.; De Pauw, M.; van Glabbeke, M. Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 12:587-591; 1986.
42. Wan, J.; Guo, B. Z.; Gao, S. Z. Accelerated hyperfractionation radiotherapy in esophageal cancer. An analysis of 172 cases. Chin. Med. J. Engl. 104:228-229; 1991.
43. Williams, M. V.; Denekamp, J.; Fowler, J. F. A review of α/β ratios for experimental tumors: Implications for clinical studies of altered fractionation. Int. J. Radiat. Oncol. Biol. Phys. 11:87-96; 1985.
44. Withers, H. R.; Peters, L. J.; Thames, H. D.; Fletcher, G. H. Hyperfractionation. Int. J. Radiat. Oncol. Biol. Phys. 8:1807-1809; 1982.
45. Yusuf, S.; Peto, R.; Collins, R.; Sleight, P. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog. Cardiovasc. Dis. 27:335-371; 1985.
46. Zietman, A. L.; Suit, H. D.; Tomkinson, K. N.; Thames, H. D.; Sedlacek, R. S. The response of two human tumor xenografts to fractionated irradiation. The derivation of the α/β ratios from growth delay, tumor control, and in vitro cell survival assays. Int. J. Radiat. Oncol. Biol. Phys. 18:569-575; 1990.